Overcoming Barriers to Accessing Spravato: A Guide for Practice Owners

Understanding Insurance Coverage Limitations

A major barrier to accessing Spravato is insurance coverage requirements. Many insurance plans require documentation that patients have tried at least two other traditional treatments before they’ll approve Spravato. In fact, a study published in the Journal of Managed Care & Specialty Pharmacy found that these policies cause treatment delays for about half of all prospective patients.

These delays are more than an administrative hassle. When treatment is stalled, patients often lose hope, disengage from care, or experience worsening depression — sometimes with life-threatening consequences.

So, instead of waiting for a denial, you have to get ahead of these delays. You can do that by staying informed about the insurance policies that affect your patients. You won't get the runaround that most practices face from generic billing companies. You know and understand the specific documentation required for Spravato, from the number of failed trials to the urgency of treating a patient with treatment-resistant depression (TRD).

With this specific knowledge, the path to healing becomes clear and efficient. Your patients get faster access to a life-changing treatment, and you get paid for the expert care you provide.

Navigating Prior Authorization Challenges

Prior authorization is another common obstacle. A prior authorization is a major roadblock that forces you to prove a patient's medical necessity before the patient’s insurance company — whether private, Medicare, or Medicaid — agrees to cover the treatment. For a practice that's focused on cutting-edge treatments like Spravato, this can be a significant issue and cause delays that put patients at risk.

Over 30% of prior authorizations are delayed because of something as simple as a missing form or an error on the claim. For a patient in a mental health crisis, these delays aren't just an inconvenience; they can lead to a serious worsening of symptoms.

While you can't eliminate the process, you can streamline it. The key is to prepare. Gather all the necessary documentation ahead of time. Nothing is too small or too insignificant to document. Every detail, from the number of failed antidepressant trials to the patient's specific symptoms, is a critical piece of the puzzle.

Think of it as taking the process by the horns — owning it instead of letting it own you. By anticipating insurer demands, you transform prior authorizations from an unpredictable barrier into a manageable (though annoying) step.

Addressing High Out-of-Pocket Costs

Even when insurance covers Spravato, high deductible plans can still lead to prohibitive out-of-pocket costs. Research suggests that nearly 45% of patients forgo treatment because they simply cannot afford their share of the costs.

Imagine a patient who finally feels hope after years of failed medications — only to see a treatment estimate that makes them feel hopeless all over again. That’s where your guidance becomes crucial. A patient who is clinically a perfect candidate for Spravato may never receive it unless someone helps them through the financial side of care.

Providers who proactively bring up financial assistance options can break down this barrier before it becomes overwhelming. Janssen, Spravato’s manufacturer, offers patient assistance programs that may help reduce costs for eligible individuals. In addition, discussing payment plans, exploring secondary coverage, or walking patients through the appeals process for insurance denials can make treatment more realistic and less intimidating.

When you open the door to these conversations early, you’re not just tackling dollars and cents — you’re building trust. Patients see that you’re committed to making treatment accessible, which strengthens the therapeutic relationship and makes them more likely to stay committed to their treatment plan.

Combating Stigma Surrounding Mental Health Treatment

Stigma is still one of the biggest barriers in mental health care, and Spravato isn’t immune to it. Some patients worry about what friends or family will think if they pursue treatment. Others feel ashamed of “needing” help at all. And because Spravato is less familiar than traditional antidepressants, the uncertainty can add another layer of hesitation.

This is where providers can shift the narrative. Normalizing conversations about mental health and framing Spravato as a safe, evidence-based option can go a long way. When patients feel that their provider sees treatment as routine and nothing to be ashamed of, they’re more likely to take that first step.

Creating an inviting space where questions are welcomed and concerns are addressed openly can transform stigma from a barrier into an opportunity for healing.

Moving Forward Together: A Collaborative Approach

Spravato can change lives, but getting patients to treatment isn’t always simple. From insurance headaches to prior authorizations, high costs, REMS requirements, and stigma, the road is full of obstacles. For some patients, those hurdles feel insurmountable.

That’s where you come in. Providers who know the system — and who are willing to walk patients through it — make all the difference. Whether it’s anticipating insurance demands, connecting patients with financial assistance, or simply normalizing conversations about mental health, each step you take helps clear the path.

The work isn’t easy, but it matters. With persistence and advocacy, more patients can access Spravato and get the chance to experience meaningful relief. Moving forward together, we can make treatment not just available, but truly accessible.

Learn how to master insurance navigation, streamline prior authorizations with proven templates, and connect patients to financial assistance through Ketamine Academy's Spravato FastTrack - the done-with-you system that transforms administrative barriers into a predictable 90-day implementation process.

A healthcare facility that provides mental health treatment